Cryotechnology for removing necrotic pancreatic tissue
Official title: Necrosectomy With Cryotechnology for Accelerated Removal
Run by Brigham and Women's Hospital · NCT06553651 · Data updated 2026-11-12
This study is testing a new freezing technique to see if it can help doctors remove dead tissue from the pancreas more effectively in patients with severe pancreatitis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | December 2026 |
| Main results expected | December 2028 |
| Study ends | June 2029 |
| Registry record updated | June 25, 2026 |
| Trial ID | NCT06553651 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with symptomatic pancreatic necrosis resulting from acute pancreatitis and significant necrotic material as indicated by imaging.
✕Probably not a fit
Patients who are unable to provide informed consent or have contraindications such as significant vascular issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the use of cryotechnology in conjunction with direct endoscopic necrosectomy (DEN) to enhance the removal of necrotic pancreatic tissue in patients suffering from pancreatic necrosis due to acute pancreatitis. The procedure aims to improve the effectiveness of current endoscopic methods, which often struggle with sticky necrotic tissue. Participants will undergo repeated endoscopic procedures to assess the efficacy and safety of this innovative approach. The study is designed to provide insights into better management strategies for a condition that carries significant morbidity and mortality.
Why it matters
Potential benefit: If successful, this approach could lead to more effective and safer treatment options for patients with pancreatic necrosis.
How similar studies have gone: While the use of cryotechnology in this context is relatively novel, similar endoscopic approaches have shown promise in managing pancreatic necrosis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects aged 18 years and above, inclusive of both males and females. * Patients with symptomatic pancreatic necrosis resulting from acute pancreatitis, indicated for endoscopic necrosectomy following endoscopic ultrasound (EUS)-guided drainage. * Imaging indicative of ≥30% necrotic material within the pancreas. * Walled-off pancreatic necrosis (WOPN) size ≥6 cm. * Subjects able to tolerate repeated endoscopic procedures. * Capacity for providing informed consent. * Understanding of study requirements, provision of written informed consent, and willingness and ability to attend required follow-up assessments through 21 (+/- 7) days. Exclusion Criteria: * Inability to provide informed consent. * Unwillingness to undergo repeated endoscopies. * Presence of documented Pseudoaneurysm \> 1cm within the WOPN. * Intervening gastric varices or unavoidable blood vessels within the access tract. * Use of dual antiplatelet therapy or therapeutic anticoagulation that cannot be temporarily discontinued. * Any condition deemed by the investigator to compromise the safety of undergoing an endoscopic procedure. * Pregnancy, lactation, or absence of reliable contraception in women of childbearing potential. * Current enrollment in another investigational trial with potential to interfere with this study's endpoint analyses.
Where it's running
-
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Christopher C. Thompson, MD, MSc — Brigham and Womens Hospital
- Study coordinator: Michele Ryan, MS
- Email: mryan@bwh.harvard.edu
- Phone: 617-525-8266
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry of patients treated for pancreatic fluid collections
This study looks at how well endoscopic treatments, like draining fluid and removing dead tissue, work for people with pancreatic fluid collections caused by pancreatitis.
-
Local complications of acute pancreatitis and postoperative pancreatic fistula: what happens in real life
This multicenter registry tests how local pancreatic complications are managed in routine care and what outcomes look like over 180 days for adults.
-
SGC001 is being tested to help predicted severe acute pancreatitis
Researchers are testing SGC001 vs placebo in adults with predicted severe acute pancreatitis to see if it is safe and tolerable and to get a sense of any early effects.
-
Fecal microbiota transplant to prevent infections after late-phase severe acute pancreatitis
This trial will test whether giving healthy donor gut bacteria (fecal microbiota transplantation) through a feeding tube in the late phase of moderately severe or severe acute pancreatitis can prevent infectious complications.
-
Nasojejunal versus oral feeding after endoscopic drainage of walled-off pancreatic necrosis
This will see if feeding through a tube into the small intestine (nasojejunal feeding) works better than eating by mouth for adults undergoing endoscopic drainage of walled-off pancreatic necrosis.
-
How often splanchnic vein clots occur in acute pancreatitis and whether they relate to disease severity
This project will see if people with acute pancreatitis develop blood clots in the splenic, portal, or superior mesenteric veins and whether those clots are linked to more severe illness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.